Showing results (241-250 of 658) with videos related to
Sort By:
Pageof 66
British Journal of Haematology|September 1, 1996
Myelodysplasia following aplastic anaemia-paroxysmal nocturnal haemoglobinuria syndrome after treatment with immunosuppression and G-CSF: evidence for the emergence of a separate cloneJ Y Jin, J A Tooze, J C Marsh, et al.Cryobiology|December 1, 1989
Hypothermic preservation of hepatocytes. I. Role of cell swellingD C Marsh, S L Lindell, L E Fox, et al.Journal of Neuro-Oncology|December 16, 2014
Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 casesJames C Marsh, Stewart Goldman, Ellis Ziel, et al.Journal of Addiction Medicine|November 18, 2021
Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist TreatmentTea Rosic, Leen Naji, Nitika Sanger, et al.Drug and Alcohol Review|June 27, 2020
Self-managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatmentHeather Palis, Scott Harrison, Scott MacDonald, et al.Substance Use : Research and Treatment|June 26, 2025
A Qualitative Study to Explore Feasibility of Implementing Seeking Safety and Trauma-Sensitive YogaTeresa Naseba Marsh, Farah Tahsin, Kristen A Morin, et al.The Journal of Biological Chemistry|August 10, 1981
Europium(III) binding to bovine prothrombin residues 1-39 and to bovine prothrombin fragment 1H C Marsh, M M Sarasua, D A Madar, et al.Hybridoma|December 1, 1989
Two distinct immunogenic epitopes on the alpha chain of human T cell antigen receptorL Henry, W T Tian, C Rittershaus, et al.British Journal of Haematology|April 1, 1997
G-CSF-mobilized CD34 peripheral blood stem cells are significantly less apoptotic than unstimulated peripheral blood CD34 cells: role of G-CSF as survival factorN J Philpott, R L Prue, J C Marsh, et al.American Journal of Clinical Oncology|October 22, 1998
Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology GroupM A Rosenthal, M Green, P Wiernik, et al.Pageof 66